Table 2.
Category | Male | Female | Total |
---|---|---|---|
Hodgkin Lymphoma n = 25 | |||
Mixed Cellularity (MC) | 4 (16%) | 8 (32%) | 12 (48%) |
Lymphocyte Predominant (LP) | 3 (12%) | 2 (8%) | 5 (20%) |
Nodular Sclerosis (NS) | 4 (16%) | 4 (16%) | 8 (32%) |
Non-Hodgkin Lymphoma n= 25 | |||
Diffuse Large Cell Type | 4 (16%) | 10 (40%) | 14 (56%) |
Small Lymphocytic Lymphoma | 1 (4%) | 1 (4%) | |
High Grade Immunoblastic Lymphoma | 1 (4%) | 1 (4%) | |
Mixed Small and Large | 2 (8%) | 2 (8%) | |
Malignant T Cell | 2 (8%) | 2 (8%) | 4 (16%) |
Malignant B Cell | 1 (4%) | 1 (4%) | 2 (8%) |
Diffuse Mixed Large Cell | 1 (4%) | 1 (4%) |